Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 738061

Visfatin is not associated with inflammatory markers in patients on hemodialysis


Ćelap, Ivana; Šimundić, Ana-Maria; Nikolac, Nora; Miler, Marijana; Altabas, Karmela; Šefer, Siniša
Visfatin is not associated with inflammatory markers in patients on hemodialysis // Biochemia Medica / Šimundić, Ana-Maria (ur.).
Zagreb: Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012. str. A188-A188 (poster, nije recenziran, sažetak, znanstveni)


CROSBI ID: 738061 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Visfatin is not associated with inflammatory markers in patients on hemodialysis

Autori
Ćelap, Ivana ; Šimundić, Ana-Maria ; Nikolac, Nora ; Miler, Marijana ; Altabas, Karmela ; Šefer, Siniša

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Biochemia Medica / Šimundić, Ana-Maria - Zagreb : Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012, A188-A188

Skup
2nd European Joint Congress of EFLM and UEMS and 7th Congress of the Croatian Society for Medical Biochemistry and Laboratory medicine (CSMBLM): Laboratory Medicine at the Clinical Interface

Mjesto i datum
Dubrovnik, Hrvatska, 10.10.2012. - 13.10.2012

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
chronic renal disease; inflamation; visfatin

Sažetak
Patients with chronic renal disease often suffer from diverse cardiovascular complications. Endothelial dysfunction has been involved in development of different forms of the cardiovascular diseases, including chronic renal disease. In recent years, ubiquitous adipokine called visfatin has been considered as a novel marker of endothelial dysfunction and inflammation. Thus, the aim of our study was to investigate the association of serum visfatin concentrations and well-established markers of cardiovascular risk in the patients on hemodialysis. Serum and plasma samples from 66 patients (40 males and 26 females) treated by hemodialysis were analysed for visfatin, fibrinogen, CRP and PAI-1 levels. Visfatin was determined by ELISA method while CRP, fibrinogen and PAI-1 were obtained by standard laboratory methods. Visfatin did not correlate with the studied markers of inflammation (CRP (r =-0.05, P = 0.152) ; PAI-1 (r = -0.08, P = 0.558) and fibrinogen (r = 0.04, P = 0.772)). Statistically significant correlation between visfatin level and fibrinogen (r = 0.51 ; P = 0.008) and the time on dialysis (r = 0.70 ; P < 0.001) was observed in female patients. In conclusion, visfatin is not associated with CRP, fibrinogen and PAI-1 in patients on hemodialysis.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
134-1340227-0200 - Upala i udio farmakogenetike u razvoju i ishodu akutnih i kroničnih bolesti (Šimundić, Ana-Maria, MZOS ) ( CroRIS)

Ustanove:
KBC "Sestre Milosrdnice"


Citiraj ovu publikaciju:

Ćelap, Ivana; Šimundić, Ana-Maria; Nikolac, Nora; Miler, Marijana; Altabas, Karmela; Šefer, Siniša
Visfatin is not associated with inflammatory markers in patients on hemodialysis // Biochemia Medica / Šimundić, Ana-Maria (ur.).
Zagreb: Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012. str. A188-A188 (poster, nije recenziran, sažetak, znanstveni)
Ćelap, I., Šimundić, A., Nikolac, N., Miler, M., Altabas, K. & Šefer, S. (2012) Visfatin is not associated with inflammatory markers in patients on hemodialysis. U: Šimundić, A. (ur.)Biochemia Medica.
@article{article, author = {\'{C}elap, Ivana and \v{S}imundi\'{c}, Ana-Maria and Nikolac, Nora and Miler, Marijana and Altabas, Karmela and \v{S}efer, Sini\v{s}a}, editor = {\v{S}imundi\'{c}, A.}, year = {2012}, pages = {A188-A188}, keywords = {chronic renal disease, inflamation, visfatin}, title = {Visfatin is not associated with inflammatory markers in patients on hemodialysis}, keyword = {chronic renal disease, inflamation, visfatin}, publisher = {Hrvatsko dru\v{s}tvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM)}, publisherplace = {Dubrovnik, Hrvatska} }
@article{article, author = {\'{C}elap, Ivana and \v{S}imundi\'{c}, Ana-Maria and Nikolac, Nora and Miler, Marijana and Altabas, Karmela and \v{S}efer, Sini\v{s}a}, editor = {\v{S}imundi\'{c}, A.}, year = {2012}, pages = {A188-A188}, keywords = {chronic renal disease, inflamation, visfatin}, title = {Visfatin is not associated with inflammatory markers in patients on hemodialysis}, keyword = {chronic renal disease, inflamation, visfatin}, publisher = {Hrvatsko dru\v{s}tvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM)}, publisherplace = {Dubrovnik, Hrvatska} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font